SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-012185
Filing Date
2017-10-31
Accepted
2017-10-31 06:16:06
Documents
42
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 566550
2 ex31-1.htm EX-31.1 11971
3 ex31-2.htm EX-31.2 12441
4 ex32-1.htm EX-32.1 9668
  Complete submission text file 0001493152-17-012185.txt   2065673

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE rttr-20170930.xml EX-101.INS 240986
6 XBRL SCHEMA FILE rttr-20170930.xsd EX-101.SCH 22751
7 XBRL CALCULATION FILE rttr-20170930_cal.xml EX-101.CAL 26599
8 XBRL DEFINITION FILE rttr-20170930_def.xml EX-101.DEF 75941
9 XBRL LABEL FILE rttr-20170930_lab.xml EX-101.LAB 185368
10 XBRL PRESENTATION FILE rttr-20170930_pre.xml EX-101.PRE 140345
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 171163976
SIC: 2834 Pharmaceutical Preparations